[HTML][HTML] DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Y Handelsman, JE Anderson, GL Bakris… - Metabolism, 2024 - Elsevier
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …

Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids

T Dong, W Zhu, Z Yang, NMM Pires, Q Lin… - Biosensors and …, 2024 - Elsevier
Cardiovascular diseases (CVDs), especially chronic heart failure, threaten many patients'
lives worldwide. Because of its slow course and complex causes, its clinical screening …

[HTML][HTML] “When,”“where,” and “how” of SARS-CoV-2 infection affects the human cardiovascular system: a narrative review

NG Kounis, C Gogos, C de Gregorio… - Balkan Medical …, 2024 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute
respiratory coronavirus-2 (SARS-CoV-2). Several explanations for the development of …

[HTML][HTML] Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome–a case-control study

S Rigo, V Urechie, A Diedrich, LE Okamoto… - Bioelectronic …, 2023 - Springer
Purpose Eighty percent of patients infected by SARS-CoV-2 report persistence of one
symptom beyond the 4-week convalescent period. Those with orthostatic tachycardia and …

[HTML][HTML] Examination of Cardiac Activity with ECG Monitoring Using Heart Rate Variability Methods

G Georgieva-Tsaneva, E Gospodinova… - Diagnostics, 2024 - mdpi.com
The paper presents a system for analyzing cardiac activity with the possibility of continuous
and remote monitoring. The created sensor mobile device monitors heart activity by means …

[HTML][HTML] Cardiovascular complications of COVID-19: a scoping review of Evidence

A Ntchana, S Shrestha, M Pippin - Cureus, 2023 - ncbi.nlm.nih.gov
This scoping review sought to identify the nature and extent of clinical evidence regarding
the acute and long-term cardiovascular complications associated with COVID-19. Forty-nine …

[HTML][HTML] Pathogenic mechanisms of cardiovascular damage in COVID-19

HH Shao, RX Yin - Molecular Medicine, 2024 - Springer
Background COVID-19 is a new infectious disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS CoV-2). Since the outbreak in December 2019, it has …

[HTML][HTML] Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020–2021) in 12 Countries of the C-MOR Consortium

VV Beeks, S Achilleos, A Quattrocchi, CT Pallari… - Journal of Epidemiology …, 2024 - Springer
Background This study investigated cause-specific mortality rates in 12 countries during the
COVID-19 pandemic in 2020 and 2021. Methods We collected weekly cause-specific …

Lingering effects of COVID-19 in the care of perioperative patients

L Jia, S Navare, M Hoyler - Current Opinion in Anesthesiology, 2024 - journals.lww.com
This review offers anesthesiologists an organ system-based approach to patients with a
history of COVID-19. Recognizing the long-term sequelae of SARS-CoV-2 infection can help …

[HTML][HTML] Preventing and Managing Chronic Disease Through Implementation Science: Editor's Introduction to the Supplemental Issue

JD Smith, SF Naoom, L Saldana, S Shantharam… - Prevention …, 2023 - Springer
People living with cardiovascular disease and other chronic conditions had a greater risk of
complications and death during the COVID-19 pandemic (Abbasi, 2022; Clerkin et al., 2020; …